Diabetes abolishes sildenafil-induced cGMP-dependent protein kinase-I expression and cardioprotection. [electronic resource]
Producer: 20080227Description: 670-6 p. digitalISSN:- 0160-2446
- Alloxan -- toxicity
- Animals
- Blood Glucose -- metabolism
- Blotting, Western
- Cardiotonic Agents -- administration & dosage
- Collateral Circulation -- drug effects
- Coronary Circulation -- drug effects
- Cyclic GMP-Dependent Protein Kinases -- metabolism
- Diabetes Mellitus, Experimental -- blood
- Dogs
- Dose-Response Relationship, Drug
- Hemodynamics -- drug effects
- Immunochemistry
- Injections, Intravenous
- Microspheres
- Myocardial Infarction -- metabolism
- Phosphodiesterase 5 Inhibitors
- Phosphodiesterase Inhibitors -- administration & dosage
- Piperazines -- administration & dosage
- Purines -- administration & dosage
- Radioisotopes
- Sildenafil Citrate
- Streptozocin -- toxicity
- Sulfones -- administration & dosage
- Up-Regulation
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.